Hepatology

Top Story

HCV liver cancer resection outcomes similar in patients with diabetes

January 16, 2018
In the Journals

NASH, HCV cirrhosis predict coronary artery disease in liver transplantation

January 16, 2018
Patients who underwent liver transplantation evaluation had a high prevalence of coronary artery disease, especially those with nonalcoholic steatohepatitis-related…
In the Journals

Hepatitis A vaccines effective in high-risk populations during outbreak

January 15, 2018
Two-dose hepatitis A vaccination was an effective preventive measure among HIV-positive individuals, including a high study population of men who have sex with men…
In the Journals

Acute-on-chronic liver failure model accurately predicts 30-day survival

January 15, 2018
Investigators have validated the North American Consortium for the Study of End-Stage Liver Disease Acute-On Chronic Liver Failure model, or NACSELD-ACLF, as an accurate…

Heplisav-B HBV vaccine for adults available in US

January 12, 2018
Dynavax announced in a recent press release its hepatitis B vaccine, Heplisav-B, is now available in the U.S. “Dynavax is prepared and proud to launch our first…
More Headlines »
Current Issues Current Issues
View the Current Issue
HCV Next
Advertisement
Advertisement